Did not become law. It stopped in the Senate's Banking & Insurance Committee on March 25, 2020. The 2019–2020 session has ended.
2019–2020 Regular Session
Senate Bill 1091
An Act providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; and establishing the Pharmaceutical Transparency Review Fund.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the Senate
Sponsor
Its course
March 25 to March 25, 2020, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action1 action on 1 day
In the SenateMar 25 to Mar 25 · stopped0 days
Banking & InsuranceMar 25 to Mar 25 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Mar 25
- Mar 25Sent to BANKING AND INSURANCE
All 1 actions, as published
- Mar 25Referred to BANKING AND INSURANCE, March 25, 2020 [Senate]Senate